BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

This study proposes a cross-species transcriptomic framework to predict vaccine reactogenicity, with implications for preclinical vaccine safety assessment. The findings show that mouse muscle ...

The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected ...

The GeneTitan® family of instruments and proven GeneChip® Array Plates from Thermo Fisher Scientific are the first to provide a hands-free, automated solution for monitoring gene expression and genome ...

Growing Adoption of Growth Hormone Therapy, Expanding Estrogen Replacement Programs, and Government-Backed Rare Disease Initiatives Accelerate Turner Syndrome Market Growth.Austin, United States, Feb.

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA ...

The global scar treatment market is growing robustly, expected to be valued at around US$ 23.0 billion in 2026 and projected to reach US$ 49.2 billion by ...

Abstract: Microarray expression data contains observations from thousands of genes across hundreds of samples. To extract meaningful information from these large datasets, the dimensionality reduction ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare ...

Charles River Laboratories International (NYSE:CRL) reported fourth-quarter and full-year 2025 results that landed at the high end of management’s November outlook, while outlining 2026 guidance that ...

The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and ...

The global growth factors market is growing steadily, expected to be valued at approximately US$2.5 billion in 2026 and projected to reach US$3.7 billion ...